Development of a radiogallium-labeled tumor imaging agent that recognizes negative charged region<br />and integrin on the surface of cancer cell membrane.

○Kohei Shimo

2:06 PM - 2:18 PM

[26H-pm04S] Development of a radiogallium-labeled tumor imaging agent that recognizes negative charged region
and integrin on the surface of cancer cell membrane.

○Kohei Shimo¹, Takeshi Fuchigami¹, Kenji Mishiro², Kazuhiro Shiba³, Seigo Kinuya¹, Kazuma Ogawa^1,2 (1. Grad. Sch. Med. Sci., Kanazawa Univ., 2. InFiniti., Kanazawa Univ., 3. Dis. Mod., Kanazawa Univ.)

A password that applicants have been notified of is required to view abstracts.
If you are a participant and need to confirm the password, please contact us by e-mail about which annual meeting you would like to know the password for to view abstracts.
We will reply after confirming that you were a participant.
Thank you for your understanding.

Presentation information

[26H-pm] Radiopharmaceuticals-1

[26H-pm04S] Development of a radiogallium-labeled tumor imaging agent that recognizes negative charged region
and integrin on the surface of cancer cell membrane.

Password

Presentation information

[26H-pm] Radiopharmaceuticals-1

[26H-pm04S] Development of a radiogallium-labeled tumor imaging agent that recognizes negative charged regionand integrin on the surface of cancer cell membrane.

Password

[26H-pm04S] Development of a radiogallium-labeled tumor imaging agent that recognizes negative charged region
and integrin on the surface of cancer cell membrane.